AVZ
Click for more information
0.00% 78.0¢ avz minerals limited

AVZ chart, page-11337

  1. Mining8
    2,362 Posts.
    lightbulb Created with Sketch. 5677
    clock Created with Sketch.
    05/11/21
    11:52
    Post #: 57342020
    Couldn't have nailed it better AVZ is about R.E.A.L. fundamentals and NOT pump!

    Seen some very good signs this morning up to 49.5, then some consolidation, and whenever the opportunity arises 48.5 line is getting completely wiped. Solid volume and VWAP 48.6.

    Expecting a push to break 50c later!



    AVZ short term rerating catalysts:

    -collaboration agreement and HEPP

    -SEZ-tax, royalty and duty benefits including VAT exemption and tax holiday increasing the economic bottom line and decreasing an already amazingly short payback period

    -mining licence

    -BFS-expecting major increase in already stellar NPV/IRR, plus shortened payback period with increased resource from wedge drilling, tax benefits from SEZ, the huge increase in output to a 10 Mtpa plant (2 times greater than PLS 2 plants combined!eek.png who have a MC OF 6.9Bn )+ 2 primary lithium sulphate trains




    -more funding to add to our $400 million from CATH(CATL-the largest lithium ion battery maker in the world needing AVZ's lithium to meet their multibillion dollar contracts)...expecting 2.1 billion overall according to the DRC Industrial Minister Julien Paluku, I quote


    -feasibility study for hydroxide plant

    -further offtakes with big hitters

    AIMO


    AVZ Price at posting: 49.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 52  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RLT South Africa-based Renergen brings liquid helium facility online
right-arrow Created with Sketch.
NEWS Bitcoin: Current State of Play & Where to Next | Swyftx
right-arrow Created with Sketch.
TG6 TG Metals reports high grade lithium hits approaching 3% at Jaegermeister
right-arrow Created with Sketch.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
right-arrow Created with Sketch.
NEWS Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market
right-arrow Created with Sketch.
QBE QBE records share price plunge despite doubling profits in the first half of 2024
right-arrow Created with Sketch.
watchlist Created with Sketch. Add AVZ (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.